Bixiye
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3501 - 3510 ee natiijooyinka 3562
Bixiye
Pulmonary Arterial Hypertension - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Resmetirom - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Oral Inhalers - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Growth Hormone - Commercial
Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Otezla (apremilast) - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Oral NSAID (Nonsteroidal Anti-Inflammatory Drugs) - Commercial
Step Therapy
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Elagolix/Relugolix - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Gabapentin ER (extended-release) [Horizant, Gralise] - Commercial
Step Therapy, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026
Bixiye
Dry Eye Disease - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Jan 01, 2026